MetaCap

MAIA Biotechnology Insider Trades

NYSE: MAIAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.22+0.07 (+6.09%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
11 · $626.09K
Sales
0 · $0
Shares bought / sold
464.97K / 0
Net activity
Net buying $626,092

MAIA Biotechnology insider activity

Over the last 12 months, MAIA Biotechnology insiders reported 11 transactions on SEC Form 4: 11 open-market purchases and 0 sales. Insiders bought $626,092 and sold $0 worth of stock, for net insider buying of $626,092. The most recent filing shows Vitoc Vlad (Chief Executive Officer) buying 73,000 shares at $1.37 on Sep 14, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MAIA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

MAIA insider transactions

MAIA Biotechnology insider transactions
DateInsiderTypeSharesValueFiling
Sep 14, 2026Vitoc VladChief Executive OfficerBuy73,000$100.01KForm 4
Sep 10, 2026Guerrero RamiroDirectorBuy37,595$49.52KForm 4
Aug 28, 2026Guerrero RamiroDirectorBuy46,620$62.94KForm 4
Aug 27, 2026Guerrero RamiroDirectorBuy78,239$108.75KForm 4
Aug 26, 2026Guerrero RamiroDirectorBuy8,931$12.41KForm 4
Aug 24, 2026Guerrero RamiroDirectorBuy1,794$2.39KForm 4
Aug 20, 2026Guerrero RamiroDirectorBuy11,899$16.30KForm 4
Jun 1, 2026Vitoc VladChief Executive OfficerBuy72,700$100.89KForm 4
Jun 1, 2026Gryaznov SergeiChief Scientific OfficerBuy2,000$2.69KForm 4
Jun 1, 2026Smith StanDirectorBuy75,000$100.20KForm 4
Dec 22, 2025Smith StanDirectorBuy57,189$70.00KForm 4
May 1, 2024Smith StanDirectorGift20,000—Form 4
Sep 19, 2022Smith StanDirectorBuy2,700$9.96KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related